MS
Morgan Stanley
MS has the edge over TRIN overall, supported by stronger fundamentals and stronger modeled upside.
TRIN
Trinity Capital Inc.
TRIN trails on the overall score without a compensating advantage in the available component scores.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
TRIN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| N/A | |
| N/A |
TRIN's profitability is currently stable, but its revenue is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like TRIN.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS has the edge over TRIN in the historical PE scenario, which offers more potential upside but is not a forecast.
TRIN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.3x | $9.73 | -46% |
| Fair | 7.1x | $13.17 | -26% |
| Forward | 8.6x | $17.87 | — |
| Expensive | 8.9x | $16.54 | -7.5% |
| Current | 9.7x | $17.87 | — |
Historical ranges are pointers, not guarantees.
TRIN's PE is in its expensive range at 9.7x. On analysts' estimates for next year's earnings, today's price would be 8.6x.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over TRIN on the outlook, with more favorable earnings and profitability expectations.
TRIN Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Stable | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect TRIN's revenue to grow, but its profitability to weaken.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over TRIN on earnings, with more consistent year-over-year improvement.
TRIN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.09 | +13% |
| Q3 2026 | $1.85 | -17% |
| Q2 2026 | $1.75 | -23% |
| Q1 2026 | $1.89 | -15% |
| Q4 2025 | $1.96 | -6.7% |
| Q3 2025 | $2.23 | +32% |
| Q2 2025 | $2.27 | +37% |
| Q1 2025 | $2.23 | +40% |
| Q4 2024 | $2.10 | +11% |
TRIN earned $1.85 per share over the past year, down 17% from the year before.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over TRIN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
TRIN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1M | +43% |
| Q2 2026 | $1.1M | -27% |
| Q1 2026 | $900K | -40% |
| Q4 2025 | $1.2M | -29% |
| Q3 2025 | $700K | -56% |
| Q2 2025 | $1.5M | 0% |
| Q1 2025 | $1.5M | -63% |
| Q4 2024 | $1.7M | -35% |
TRIN's revenue is recovering but still below its 2024 peak: $1M last quarter, up 43% from the same quarter a year ago.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
TRIN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$66.3M | +$117.3M |
| Q2 2026 | -$198.6M | -$75.1M |
| Q1 2026 | -$45.8M | +$17.6M |
| Q4 2025 | -$165M | -996% |
| Q3 2025 | -$183.6M | +$48.4M |
| Q2 2025 | -$123.5M | -$101.6M |
| Q1 2025 | -$63.3M | +$18.1M |
| Q4 2024 | $18.4M | +$154.8M |
TRIN has the edge over MS on cash flow, with more consistent year-over-year improvement.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
TRIN Net Leverage
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
TRIN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.3 | Neutral |
| Stochastic | 57.2 | Neutral |
TRIN's weekly RSI is 57 (neutral) and its Stochastic is 57 (neutral).
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
TRIN PE vs Financial Services Sector
| Metric | TRIN | Sector median | Relative |
|---|---|---|---|
| PE | 9.7x | 13x | 26% below |
| PE % | 95 | 62 | 33 pts above |
TRIN has the edge over MS on valuation relative to its sector.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
TRIN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.2 | 4% above |
| 20 week MA | $17.6 | 1.5% above |
| 50 week MA | $16.5 | 8.2% above |
| 100 week MA | $15.8 | 13% above |
| 200 week MA | $14.9 | 20% above |
TRIN has the edge over MS on trend strength, trading above more of its moving averages.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.
TRIN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $15.0 | $17.3 | +15% |
| 2022 | $17.3 | $11.7 | -33% |
| 2023 | $11.7 | $14.5 | +25% |
| 2024 | $14.5 | $14.8 | +1.8% |
| 2025 | $14.8 | $15.2 | +2.8% |
| 2026 YTD | $15.2 | $17.9 | +18% |
TRIN has the edge over MS on returns for 2026, with the stronger performance.